Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
about
Thrombotic microangiopathy associated with proteasome inhibitorsA new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryHematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatmentTransplant-associated thrombotic microangiopathy: opening Pandora's box.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection.Early complications following haematopoietic SCT in children.Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.Thrombotic microangiopathies: multimers, metalloprotease, and beyond.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.Complete recovery of ischemic cardiomyopathy from thrombotic thrombocytopenic purpura.Do NK cells contribute to the pathophysiology of transplant-associated thrombotic microangiopathy?ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Thrombotic microangiopathy with skin localization secondary to cytarabine-daunorubicin association: report of a case.Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisRisk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsHematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Abnormal echocardiography 7 days after stem cell transplantation may be an early indicator of thrombotic microangiopathy.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies.Pretransplant-corrected QT dispersion as a predictor of pericardial effusion after pediatric hematopoietic stem cell transplantation.The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.Histologic Features of Intestinal Thrombotic Microangiopathy in Pediatric and Young Adult Patients after Hematopoietic Stem Cell TransplantationTransplantation-Associated Thrombotic Microangiopathy in Patients Treated With Sirolimus and Cyclosporine as Salvage Therapy for Graft-Versus-Host Disease.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Post-bone marrow transplant thrombotic microangiopathy.New approaches in the diagnosis, pathophysiology, and treatment of pediatric hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Recombinant thrombomodulin for secondary thrombotic thrombocytopenic purpura.Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome.Thrombotic Thrombocytopenic Purpura: Pathogenesis, Diagnosis, and Potential Novel Therapeutics.
P2860
Q26785826-60742F8D-701D-41C9-BB06-7F144D1CBC2FQ26992169-B24D6A51-AB61-42E8-A03E-0A080BD28B5DQ28069228-F8B31F0D-B293-49E4-BAFE-80522E547D19Q30235311-88C66991-3AE1-4BCE-A760-7FC1576C0F7CQ30253063-7F34400A-6057-4FAA-9212-DFDDE70F6196Q30276550-D016E805-A519-4BD8-B607-DAAB826D5E3AQ33378414-251A8194-161D-4A59-BC0A-62D002994FFFQ33379959-03EE4522-6701-49D8-98F4-AE7EA67764C5Q33384578-4C632B72-D1FE-4800-B47F-6EA181C12864Q33386308-EF06EC75-ADD8-4C70-BCD1-CFAB15BE5DE1Q33388255-D0709E22-9A96-4169-BAA0-60F8C9DFD38CQ33389435-F3C7BD40-CEC5-4406-B51A-8C7649DCCB20Q33391308-B192A435-7795-45C6-810F-A105009B041CQ33392710-E7350ACA-18FB-429A-9A41-3853DC7DD764Q33393944-D0DE9CA6-A9D1-4F0A-90BC-717E52B47747Q33394884-471B4078-F894-47CD-9A57-D428F87090C6Q33395998-AA25550F-35D1-4A7F-A26F-EF1BA1AABF0FQ33398214-E398D445-C831-4F18-B906-A7808CD5EAAEQ33401403-DCB349FD-9D33-45A4-854C-23EFAA74238CQ33403157-ABCD5BD0-8473-43D3-957D-789FC964FE11Q33403897-03629D78-1C1F-4535-875A-77EBDE519DCFQ33413498-CC332FB6-6B21-4924-BCA2-08B2DE4D8357Q33415603-EA9AEF6D-526D-4AAA-8632-DE2288458189Q33417613-AABE4E28-9D0D-4F5D-AA97-41799BA24E72Q33417690-2F72FEAA-AAC2-4900-9F0B-A8B6AA47EE2FQ33418088-ACFCCC91-9587-4AF4-B027-7EB254B6D4B3Q33418635-47299742-73EE-478C-ABF3-3D8722ABF17CQ33418645-E38404ED-0EB5-4F35-85DE-04E867086D56Q33420131-B7F5A53B-9B7C-482A-A71B-914B600CDE34Q33424153-67F37014-D642-49F1-9E1C-07532948718CQ33424204-EF0B3C5B-31F6-49AE-854F-E386E9B068E8Q33424311-82AC03A9-4197-4862-A10C-252CC8DE83D3Q33424902-49C40858-DAB3-4441-A789-636049C71BF4Q33428744-0F8B3ECA-F755-4383-86F2-B9C23A799FAEQ33430697-1258B761-EA97-40FB-AC4E-1BC3EF4329CBQ33432069-AD629F98-6DC6-4F2E-AA0C-F48B5C34D7E0Q33433122-41D04326-998F-446E-9858-067CEE100E5DQ33436972-3C85AEE4-CE9F-47B2-A643-0FF340F1326CQ33441641-7C83A25E-D744-4A52-A1DE-022E4F8F4A97Q33443111-13D3F76A-1FC2-49CD-B2D2-FA8606C43568
P2860
Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Diagnostic criteria for hemato ...... n International Working Group.
@ast
Diagnostic criteria for hemato ...... n International Working Group.
@en
type
label
Diagnostic criteria for hemato ...... n International Working Group.
@ast
Diagnostic criteria for hemato ...... n International Working Group.
@en
prefLabel
Diagnostic criteria for hemato ...... n International Working Group.
@ast
Diagnostic criteria for hemato ...... n International Working Group.
@en
P2093
P50
P356
P1433
P1476
Diagnostic criteria for hemato ...... n International Working Group.
@en
P2093
Dietger Niederwieser
Ernst Holler
European Group for Blood and Marrow Transplantation
European LeukemiaNet
Gerard Socié
Giovanni Barosi
James N George
Joel L Moake
Karim Kentouche
Massimo Iacobelli
P304
P356
10.3324/HAEMATOL.10699
P577
2007-01-01T00:00:00Z